Navigation Links
Elekta and Philips Establish Research Consortium to Leverage a Breakthrough in Cancer Care with Integration of a Linear Accelerator and MR Imaging
Date:10/25/2012

STOCKHOLM and AMSTERDAM, Oct. 25, 2012 /PRNewswire/ -- Elekta AB (NSE: EKTAb) and Royal Philips Electronics (NYSE: PHG, AEX: PHIA) today announced that they will  expand a joint program to develop a breakthrough in cancer care with an imaging-treatment platform that merges radiation therapy and magnetic resonance imaging (MRI) technology in a single treatment system. The program for development will include a research consortium of leading radiation oncology centers and clinicians, which today includes the University Medical Center Utrecht (the Netherlands).

The establishment of the consortium marks the next step in the collaboration between Elekta, a pioneer in neurosurgery and radiation therapy systems and Philips, a leader in medical imaging systems. The consortium's mission will be to merge precision radiation delivery with MRI in a single MRI-guided radiation therapy system*. This will enable doctors to achieve exceptional soft tissue imaging during radiation therapy and to adapt treatment delivery in real-time for extremely precise cancer treatments.

"Bringing the superior soft tissue imaging of MRI and precise radiotherapy together in one device could potentially revolutionize cancer care," says Tomas Puusepp, President and CEO of Elekta AB. "The need to maximize therapeutic radiation on the target, while minimizing the exposure of healthy tissue is entirely driven by the best interests of the patient – they deserve the best chance for a cure and an improved quality of life. Elekta and Philips are leaders in the global healthcare community with a complete spectrum of expertise to fulfill this vision."

"Cancer is a major global disease that we hope to control with more targeted treatments," says Gene Saragnese, CEO Imaging Systems at Philips Healthcare. "MRI is emerging in oncology applications because of its excellent real-time 3D visualization of soft tissue. Together with our partners, all leaders in radiation ther
'/>"/>

SOURCE Elekta
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Elekta Launches New Version of Monaco Treatment Planning System with Segment Shape Optimization
2. ASRT Foundation and Elekta Award More Than $20,000 in Scholarships to Radiation Therapy Students
3. Elekta Technology at Work in 100 Percent of Americas Top Cancer Hospitals
4. Elekta to Showcase Revolutionary Agility Beam-shaping Innovation at Radiation Physics Annual Meeting
5. Elektas Gamma Knife and Radiation Therapy Systems for Cancer Treatment Take Top Three Places in 2012s Best in KLAS for Radiation Therapy
6. U.K. Cancer Patient is Worlds First to Benefit from Treatment Combining Elektas New Beam-shaping Innovation and High-speed Arc Therapy
7. Austrian Medical Center Upgrades Cancer Treatment System, Improves Patient Care with Elektas Agility Beam-shaping Device
8. Elekta and The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital Sign Strategic Alliance to Further Cancer Research
9. Elekta to Demonstrate Latest MOSAIQ OIS Innovations for Oncology Practices at 2012 ASCO Annual Meeting
10. Elekta, pioneer in treatment of cancer in brain disorders, to Move North America Headquarters to Atlanta
11. Philips and Biocompatibles Team-up to Advance Image Guided Transarterial Embolizations in Interventional Oncology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Most osteoporosis patients want a choice in the medication ... by Mission Pharmacal Company. The survey, conducted by ... community, revealed that 74 percent of osteoporosis patients surveyed ... other than a pill or a tablet. ...
(Date:1/15/2014)... N.J. , Jan. 15, 2014  Celsion Corporation (the "Company") ... has received commitments from institutional investors to purchase an ... stock in an at-the-market registered direct offering, led by ... entered into definitive purchase agreements with these investors pursuant ...
(Date:1/15/2014)... Jan. 15, 2014  Manufacturers, suppliers and distributors of ... to protect their most important business assets, intellectual ... ) Because of the highly-competitive nature ... one of the most litigious industry sectors of ...
Breaking Medicine Technology:Mission Pharmacal Conducts Online Survey of Osteoporosis Patients 2Mission Pharmacal Conducts Online Survey of Osteoporosis Patients 3Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 2Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 3Intellectual Property Insurance for Medical-related Products and Services 2
... N.J. and INDIANAPOLIS, March 29, 2011 Oral ... the updated clinical practice guidelines as a Class ... coronary intervention (PCI) after experiencing heart-related chest pain ... myocardial infarction (NSTEMI).  NSTEMI is a type of ...
... MicroCHIPS, Inc., a developer of innovative drug delivery devices ... and Trademark Office has granted U.S. Patent No. 7,892,221, ... patent in conjunction with U.S. Patent No. 7,070,590 provides ... medical devices used for implantable drug delivery systems. ...
Cached Medicine Technology:Effient® Added to Updated ACCF/AHA Clinical Guidelines for ACS-PCI Patients with Unstable Angina and Non-ST Segment Myocardial Infarction 2Effient® Added to Updated ACCF/AHA Clinical Guidelines for ACS-PCI Patients with Unstable Angina and Non-ST Segment Myocardial Infarction 3Effient® Added to Updated ACCF/AHA Clinical Guidelines for ACS-PCI Patients with Unstable Angina and Non-ST Segment Myocardial Infarction 4Effient® Added to Updated ACCF/AHA Clinical Guidelines for ACS-PCI Patients with Unstable Angina and Non-ST Segment Myocardial Infarction 5Effient® Added to Updated ACCF/AHA Clinical Guidelines for ACS-PCI Patients with Unstable Angina and Non-ST Segment Myocardial Infarction 6MicroCHIPS Announces 35th U.S. Patent for Microreservoir-Based Drug Delivery Systems 2
(Date:4/23/2014)... frozen stool from healthy, unrelated donors was safe ... diarrhea caused by Clostridium difficile , according ... Clinical Infectious Diseases and available online. Known ... effective whether given via a colonoscope or a ... make this promising treatment more readily available to ...
(Date:4/23/2014)... looking to give exercise enthusiasts the extra nudge they ... that a cyber buddy can help. , The study, ... , is the first to indicate that although a ... a software-generated partner also can be effective. , "We ... still motivate people to give greater effort while exercising ...
(Date:4/23/2014)... compound that targets an important brain receptor has a ... including relapse behavior, a University at Buffalo animal study ... this may be a novel lead compound for treating ... UB research was published as an online preview article ... study, the compound, RO5263397, severely blunted a broad range ...
(Date:4/23/2014)... (April 23, 2014) The American Gastroenterological Association ... 2014 AGA Research Scholars. The AGA Research Scholar ... to develop independent and productive research careers in ... Awards fund an additional year allowing for three ... to supporting junior faculty who are paving the ...
(Date:4/23/2014)... A team of scientists led by a researcher from ... the National University of Singapore has identified the cancer ... opens up the possibility of developing new drugs for ... cancers. , The research group, led by Dr Chan ... for the first time that a cancer-specific variant of ...
Breaking Medicine News(10 mins):Health News:Pilot study suggests ways to widen access to fecal transplants for C. diff infections 2Health News:Cyber buddy is better than 'no buddy' 2Health News:Novel compound halts cocaine addiction and relapse behaviors 2Health News:AGA announces 2014 Class of AGA Research Scholars 2Health News:Scientists identify cancer specific cell for potential treatment of gastric cancer 2Health News:Scientists identify cancer specific cell for potential treatment of gastric cancer 3
... has the second most populous Jewish community in America, ... Florida for economic opportunities, for the climate, to join ... growing Jewish population of Broward County is now declining ... University of Miami professor Dr. Ira M. Sheskin, from ...
... March 10 A recent CBS 60 Minutes ... a red wine molecule believed to largely be ... French have far more people living beyond 100 ... from heart disease than other people living in ...
... , , TUESDAY, March 10 (HealthDay News) -- The chances of ... that sells alcohol to go, according to a study by ... and around off-premise alcohol outlets were shot as the victims ... were easier targets or they were shot as the victims ...
... Omega Protein Corporation (NYSE: OME ), the ... fish meal products, today reported net income of $12.6 ... December 31, 2008, compared with net income of $12.1 ... 31, 2007.(Logo: http://www.newscom.com/cgi-bin/prnh/20030516/OMEGALOGO )For the year ended ...
... LAKEWOOD, Colo., March 10 Mesa Laboratories, Inc. ... consumables for healthcare and manufacturing quality control applications, today announced ... of Chief Executive Officer (CEO), replacing Luke R. Schmieder, who ... Mr. Schmieder is retiring from Mesa and resigning his ...
... of packaging traceability posed by regulated medical wasteCLEVELAND, ... a leader in label, packaging , promotion ... placard identification reusable labeling solution to meet stringent ... containers for biomedical waste. Subject to governmental regulations, ...
Cached Medicine News:Health News:UM study reveals demographic trend of the Jewish population in Broward County 2Health News:Researchers Report Combined Molecules in Red Wine by Far Exceed the Biological Activity of Plain Resveratrol, Consistent With the Composition of Longevinex(R) 2Health News:Researchers Report Combined Molecules in Red Wine by Far Exceed the Biological Activity of Plain Resveratrol, Consistent With the Composition of Longevinex(R) 3Health News:Shootings Linked to Alcohol-to-Go Outlets, Study Finds 2Health News:Omega Protein Reports 2008 Results 2Health News:Omega Protein Reports 2008 Results 3Health News:Omega Protein Reports 2008 Results 4Health News:Omega Protein Reports 2008 Results 5Health News:Mesa Labs Announces the Appointment of New CEO 2Health News:Mesa Labs Announces the Appointment of New CEO 3Health News:Kennedy Group Applies Its Packaging Expertise to Reusable Labeling in Handling Biomedical Waste Disposal 2Health News:Kennedy Group Applies Its Packaging Expertise to Reusable Labeling in Handling Biomedical Waste Disposal 3Health News:Kennedy Group Applies Its Packaging Expertise to Reusable Labeling in Handling Biomedical Waste Disposal 4
... surgical approach to glaucoma management that employs ... ciliary body (which produces aqueous humour) is ... or posterior segment, through the endoscope in ... and accurately identified utilizing endoscopy. This allows ...
... of German Craftsmanship have produced ... the world. Ocutek® now makes ... holders of the coveted Meisterbrief ... apprenticeship, are qualified to become ...
... Craftsmanship have produced the finest ... Ocutek® now makes them available ... the coveted Meisterbrief certificate, which ... qualified to become Ocutek instrument ...
... Craftsmanship have produced the finest ... Ocutek® now makes them available ... the coveted Meisterbrief certificate, which ... qualified to become Ocutek instrument ...
Medicine Products: